Treatment strategies for tumour diseases are progressively focusing on personalization of medicine. However, this focus requires methods revealing the early general biological mechanisms, including the formation anti-cancer drugs' resistance. The low molecular mass protein metallothionein is thought to be the crucial for the formation of resistance in tumour treatment based on the platinum-cytostatics. The interactions between metallothionein (MT) and cisplatin were determined by the adsorptive transfer stripping technique coupled with the differential pulse votlammetry Brdicka's reaction. The signals related to the MT-cisplatin complex appeared at -0.9 V. The formation of this complex depended on the time of interaction between cisplatin a...
Glutathione was discovered by M. J. de Rey Pailhade at the end of the 19th century as the substance ...
Metallodrug protein interactions contribute to their therapeutic effect (even when DNA is the domina...
Cisplatin (CDDP) is an extremely active drug in the treatment of germ-cell tumours. Earlier, we foun...
The drugs based on platinum metals represent one of the oldest, but also one of the most effective g...
The binding of cisplatin to metallothionein (MT) was investigated at 37°C in 10 mM Tris-NO3 (pH -7.4...
Human metallothioneins, small cysteine- and metal-rich proteins, play an important role in the acqui...
In an experiment on white wild-type laboratory rats, it was shown that 90 minutes after intraperiton...
Platinum-based cytostatic represent a unique class of DNA-damaging antitumor agents and they are one...
Cis-dichlorodiammineplatinum (II), commonly known as cisplatin, is a widely used anticancer drug. Ho...
Electrospray ionisation mass spectrometry was used to analyse the reactions of metal compounds with ...
Cancer is a group a diseases that involves abnormal cell growth with potential to invade or spread t...
Metallothioneins (MT) represent low molecular weight proteins that are supposed to fulfil several fu...
A critical discussion is presented about the possible role of Pt-protein interactions in the mechani...
The discovery of the anticancer activity of cisplatin and its clinical application has opened a new ...
This article reviews approaches on platinum speciation with respect to Pt drugs in anti-cancer thera...
Glutathione was discovered by M. J. de Rey Pailhade at the end of the 19th century as the substance ...
Metallodrug protein interactions contribute to their therapeutic effect (even when DNA is the domina...
Cisplatin (CDDP) is an extremely active drug in the treatment of germ-cell tumours. Earlier, we foun...
The drugs based on platinum metals represent one of the oldest, but also one of the most effective g...
The binding of cisplatin to metallothionein (MT) was investigated at 37°C in 10 mM Tris-NO3 (pH -7.4...
Human metallothioneins, small cysteine- and metal-rich proteins, play an important role in the acqui...
In an experiment on white wild-type laboratory rats, it was shown that 90 minutes after intraperiton...
Platinum-based cytostatic represent a unique class of DNA-damaging antitumor agents and they are one...
Cis-dichlorodiammineplatinum (II), commonly known as cisplatin, is a widely used anticancer drug. Ho...
Electrospray ionisation mass spectrometry was used to analyse the reactions of metal compounds with ...
Cancer is a group a diseases that involves abnormal cell growth with potential to invade or spread t...
Metallothioneins (MT) represent low molecular weight proteins that are supposed to fulfil several fu...
A critical discussion is presented about the possible role of Pt-protein interactions in the mechani...
The discovery of the anticancer activity of cisplatin and its clinical application has opened a new ...
This article reviews approaches on platinum speciation with respect to Pt drugs in anti-cancer thera...
Glutathione was discovered by M. J. de Rey Pailhade at the end of the 19th century as the substance ...
Metallodrug protein interactions contribute to their therapeutic effect (even when DNA is the domina...
Cisplatin (CDDP) is an extremely active drug in the treatment of germ-cell tumours. Earlier, we foun...